Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ARCT 810

Next Previous
Drug Profile

ARCT 810

Alternative Names: ARCT-810; LUNAR-OTC

Latest Information Update: 11 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Arcturus Therapeutics
  • Class RNA
  • Mechanism of Action Ornithine carbamoyltransferase expression stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ornithine carbamoyltransferase deficiency disease
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Ornithine carbamoyltransferase deficiency disease

Most Recent Events

  • 03 Mar 2026 Arcturus Therapeutics plans a Type C regulatory meetings with health authorities for ARCT 810, in the first half of 2026
  • 11 Aug 2025 Arcturus Therapeutics expects phase III trial design alignment with US FDA and other regulatory agencies in first half of 2026
  • 11 Aug 2025 Arcturus Therapeutics plans meetings with US FDA and other regulatory agencies to discuss design of phase III pivotal trial and paediatric studies in Ornithine carbamoyltransferase deficiency disease

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top